title: The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.
abstract: The era of molecular medicine has led to dramatically improved understanding of the genetic events that give rise to different types of cancers. In the case of gynaecological malignancies, this has resulted in distinct shifts in how these tumours are diagnosed in routine surgical pathology practice, with an increased emphasis on accurate subtype diagnosis. This has happened across all sites in the gynaecological tract and for most cell types, but in ways that are site-specific and may appear to be subtle, as in most instances the diagnostic terminology has not changed. For example, the diagnosis of clear cell carcinoma of the ovary is still in use, but the diagnostic criteria and clinical implications are different in 2017 from what they were in 2000. As a result, there can be a failure to appreciate how important these changes are and the resulting necessity of incorporating them into our daily practice. In this review we will describe changes in diagnostic surgical pathology occasioned by improved understanding of molecular events during pathogenesis, for cancers of ovary/tube, endometrium, cervix and vulva, and highlight how current practice differs from that of only a few years ago.
authors.affiliation: Department of Cellular Pathology, Barts Health NHS Trust, London, UK.
authors.forename: Naveena
authors.initials: N
authors.lastname: Singh
authors.affiliation: Department of Anatomic Pathology, Vancouver General Hospital, Vancouver, BC, Canada.
authors.forename: C Blake
authors.initials: CB
authors.lastname: Gilks
mesh_terms: D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D006801:Humans; D010340:Pathology, Surgical / Q000379:methods / Q000639:trends*
keywords: cancer; endometrial carcinoma; gynaecological classification; histopathology; molecular genetics; ovarian carcinoma; prognosis